Philipp Kiewe

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

Uwe Platzbecker, Ulrich Germing, Katharina S. Götze et al. · The Lancet Oncology · 2017 · 288 citations

Medicine, Hematology, Pharmacology +8

Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer

Philipp Kiewe, Stephan Hasmüller, Steffen Kahlert et al. · Clinical Cancer Research · 2006 · 197 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma

Agnieszka Korfel, Uwe Schlegel, Ulrich Herrlinger et al. · Journal of Clinical Oncology · 2016 · 134 citations

Medicine, Oncology, Pharmacotherapy +17

CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients

Lars Fischer, Agnieszka Korfel, Sebastian Pfeiffer et al. · Clinical Cancer Research · 2009 · 116 citations

Medicine, Immunology, Oncology +12

Detection of Subclinical Systemic Disease in Primary CNS Lymphoma by Polymerase Chain Reaction of the Rearranged Immunoglobulin Heavy-Chain Genes

Kristoph Jahnke, Michael Hummel, Agnieszka Korfel et al. · Journal of Clinical Oncology · 2006 · 88 citations

Medicine, Hematology, Oncology +14